Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

EditCo Bio has entered a licensing agreement to secure access to Promega’s protein-tagging and bioluminescent identification ...

Bristol Myers Squibb’s new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of ...

Gene therapy developer CRISPR Therapeutics AG (CRSP) is navigating some regulatory and commercial dynamics. Its flagship gene ...